A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity. [electronic resource]
Producer: 19970117Description: 527-30 p. digitalISSN:- 0007-1048
- Adolescent
- Adult
- Combined Modality Therapy
- Female
- Hematopoietic Stem Cell Transplantation -- methods
- Hodgkin Disease -- drug therapy
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Melphalan -- adverse effects
- Multiple Myeloma -- drug therapy
- Pilot Projects
- Transplantation, Autologous
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.